| GTO ID | GTC1652 |
| Trial ID | NCT02930993 |
| Disease | Malignant Mesothelioma |
| Altered gene | MESO |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | MESO CAR-T cells |
| Phase | Phase1 |
| Recruitment status | Unknown |
| Title | Anti-mesothelin CAR T Cells for Patients With Recurrent or Metastatic Malignant Tumors |
| Year | 2016 |
| Country | China |
| Company sponsor | China Meitan General Hospital |
| Other ID(s) | K16-4 |
| Cohort 1 | |||||||||||
|
|||||||||||